|
Bites and stings
Prospective study of jellyfish stings from tropical Australia,
including the major box jellyfish Chironex fleckeri
Gerard M O'Reilly, Geoffrey K Isbister, Paula M Lawrie, Greg T Treston
and Bart J Currie
MJA 2001; 175: 652-655
Abstract -
Methods -
Results -
Discussion -
Acknowledgements -
Conflict of interest -
Reference -
Authors' details
Register to be notified of new articles by e-mail -
Current contents list -
More articles on Insects, bites and stings
|
|
Objective: To determine the immediate and delayed
effects of jellyfish stings, and correlate these with microscopic
identification of jellyfish nematocysts.
Design: Prospective study of patients presenting
with jellyfish stings.
Participants and setting: 40 people presenting with
jellyfish stings to the emergency department of a teaching hospital
in tropical Australia between 1 August 1999 and 31 July 2000.
Main outcome measures: Clinical diagnosis (sting by
Chironex fleckeri, "Darwin carybdeid" or other jellyfish,
or "Irukandji" syndrome); clinical severity; delayed
hypersensitivity; and sticky-tape sampling and microscopic
identification of nematocysts.
Results: Patients were aged 2-50 years, with eight aged
under 15 years; 23 were male. Presentations were consistent with
C. fleckeri sting in 28 cases, Darwin carybdeid sting in five,
and Irukandji syndrome in four. Sticky-tape sampling was done in 39
patients and was positive for C. fleckeri nematocysts in 23
and for non-C. fleckeri nematocysts in six, with nematocysts
not detected in 10 (including all four with Irukandji syndrome). All
microscopically confirmed C. fleckeri stings had typical
clinical presentations. None of the stings were life-threatening,
and no antivenom was given. Delayed hypersensitivity reactions were
seen in 11 of the 19 patients (58%) followed up after stings positive
for C. fleckeri nematocysts.
Conclusions: Although most jellyfish stings
presenting to Royal Darwin Hospital were caused by C.
fleckeri, severe envenomation was rare. There was a strong
association between clinical features and sticky-tape
identification of nematocysts. Delayed hypersensitivity was
common after C. fleckeri stings.
|
|
| |
Box jellyfish stings have historically been an important cause of
mortality and morbidity in coastal tropical Australia.1-3 The most
common cause of sting presentations to the Royal Darwin Hospital (NT)
is the major box jellyfish Chironex fleckeri (Class Cubozoa;
Order Chirodropidae)4-6 (Box 1A). It is
responsible for most severe cases of jellyfish
envenomation.1-4 Clinical manifestations
include immediate local pain with visible linear tentacle marks and,
in severe stings, systemic effects with cardiorespiratory arrest
possible within minutes.1-4,6-8 However, fatalities
are rare, and the clinical spectrum is not evident from published case
reports, which mostly present fatal or near-fatal cases. In
addition, it is not clear whether delayed hypersensitivity, which
has been reported after other jellyfish stings, is a feature
of C. fleckeri
stings.1
The "Irukandji" syndrome has been associated with stings by
Carukia barnesi (Class Cubozoa; Order
Carybdeidae)9,10
(Box 1C), although other jellyfish may cause a
similar syndrome.11 C. barnesi has
rarely been found in the Northern Territory (P Alderslade, Curator of
Coelenterates, Museum and Art Gallery of the Northern Territory,
Darwin, NT, personal communication), and the Irukandji syndrome is
less common than in far north Queensland.10,11 Other jellyfish
species appear to cause some stings in the Darwin region.1,4 These include
the "Darwin carybdeid",1 a four-tentacled jellyfish
larger than C. barnesi, which appears to cause less severe
skin damage than C. fleckeri.
We conducted a prospective study of all jellyfish-sting
presentations to Royal Darwin Hospital over 12 months in 1999 and
2000. Our aim was to determine the immediate and delayed effects of all
marine stings, and to correlate these with microscopic
identification of jellyfish nematocysts using the sticky-tape
sampling technique.6
|
|
| |
Methods |
The study included all patients who presented to the Royal Darwin
Hospital after a jellyfish sting between 1 August 1999 and 31 July
2000. The study was approved by the Joint Institutional Ethics
Committee of the Royal Darwin Hospital and the Menzies School of
Health Research.
Patients were assessed and treated in the Emergency Department
according to the Royal Darwin Hospital protocol12 (Box 2).
Clinical and demographic details were entered prospectively, along
with details of hospital management, on a standardised form. Details
included investigations (eg, electrocardiography [ECG]), type and effect of analgesia (topical [ice], oral [eg, aspirin or
codeine], or parenteral [morphine or pethidine]) and whether C.
fleckeri antivenom was administered.
The clinical diagnosis was classified as typical or not typical of
C. fleckeri sting according to known features (immediate and
persistent local pain, linear sting marks and absence of generalised
pain, which is seen in Irukandji syndrome).1,3,11
|
Sticky-tape sampling | |
During the initial presentation, the sting site was sampled for
nematocysts using the sticky-tape technique developed in
Darwin.6 Transparent sticky tape was
applied to the site and then transferred to a microscope slide for
examination at x 100 to x 400 magnification. This allows nematocysts
of C. fleckeri to be distinguished from those of other
jellyfish on the basis of morphology (Box 1B and 1D). Presence of C.
fleckeri or other jellyfish nematocysts was determined by one of
the authors (P M L) and verified by another (B J C).
|
Follow-up |
We telephoned patients about three weeks after initial presentation
to ask about persistent or delayed effects, especially emergence of a
pruritic rash at the site of the initial sting.
|
|
| |
Results |
Forty patients presented to Royal Darwin Hospital with jellyfish
stings in the 12-month study period. They were aged two to 50 years
(median, 21 years), with eight aged under 15 years; 23 were male.
Seasonal variation in stings is shown in Box 3.
Of the 40 stings, 28 (70%) were clinically typical of C.
fleckeri, and 12 (30%) were not typical. Four of the latter were
consistent with Irukandji syndrome (minimal local erythema, and
delayed systemic symptoms, especially pain), and five with Darwin
carybdeid sting (less severe skin pain and markings, with some
"overlap" Irukandji features, such as abdominal pain). A typical
C. fleckeri sting is shown in Box 4A.
|
Sticky-tape sampling | |
Sticky-tape sampling was done in 39 patients and was positive for
nematocysts in 29 — C. fleckeri in 23 and
carybdeid-appearing nematocysts in six. Sampling was negative for
nematocysts in 10 patients, including all four with Irukandji
syndrome. Correlation between microscopic findings and clinical
presentation is shown in Box 5. All microscopically confirmed C.
fleckeri stings had typical clinical presentations. Of the six
patients with carybdeid-appearing nematocysts, five had
presentations consistent with Darwin carybdeid envenomation,
while one was more consistent with C. fleckeri.
|
Management |
None of the 40 patients had documented arrhythmias on ECG, or
pulmonary oedema. None was treated with pressure-immobilisation
bandages or C. fleckeri antivenom, and there were no deaths.
Of the 23 patients with stings positive for C. fleckeri
nematocysts, one required parenteral analgesia and nine oral
analgesia. In five, pain responded to topical ice alone, and eight
required no pain relief. None of these patients required admission.
Maximum length of tentacle marks was 5 m, followed by 4 m; both patients
had severe local pain. Three of the patients with Irukandji syndrome
and one stung by an unidentified jellyfish (no nematocysts detected
on sticky-tape sampling) required admission for analgesia.
|
Follow-up |
Twenty-nine patients were followed up, including 19 whose stings
were positive for C. fleckeri nematocysts. Of these 19, 11
(58%) had delayed hypersensitivity reactions. These comprised an
itchy red maculopapular rash dotted along the initial tentacle
contact points consistent with papular urticaria, occurring 7-14
days after first presentation (Box 4B). These reactions resolved
spontaneously in seven patients and after treatment with oral
antihistamine and topical corticosteroid cream in four.
|
|
| |
Discussion |
This is the largest prospective study of C. fleckeri stings to
date. Most previously published cases describe fatal or near-fatal
stings, and some authors quote mortality rates up to
20%.13 Our study does not support
this high mortality rate and showed that most stings were not severe,
consistent with previous Northern Territory findings.5-7
Although most C. fleckeri stings are minor and not
life-threatening, the potential exists for severe systemic
envenomation and even death. It is a concern that, despite
considerable public education, eight of our cases were in children.
The last 10 deaths from C. fleckeri envenomation in the
Northern Territory were all of children, most recently a
three-year-old girl from a remote Aboriginal community in February
1996.4 In January 2000, a
five-year-old boy died soon after a jellyfish sting near Yarrabah, in
north Queensland, presumed to be from C.
fleckeri.14
In the past, considerable attention has focused on the use of
antivenom in C. fleckeri envenomation.3,8,15-17
Indications have been cardiac arrest and arrhythmias, analgesia or
cosmesis, although evidence supporting the efficacy of antivenom
remains limited.7 None of our patients
received antivenom, as none had cardiac toxicity, and severe local
pain was controlled with appropriate analgesia. Nevertheless, it is
crucial that antivenom is available for early use in
life-threatening situations with arrhythmias or
cardiorespiratory arrest.
None of our patients had pressure-immobilisation bandages applied.
These bandages are not recommended in the Northern Territory, as they
potentially increase nematocyst discharge and are unlikely on
theoretical grounds to prevent venom absorption.7,12,18
Delayed skin eruptions have been reported after jellyfish stings,
although C. fleckeri has not been specifically
implicated.19-21 These eruptions
typically occurred at the site of the original sting after five days or
more, and were pruritic and painless.1 Their histological
features were generally consistent with delayed (type IV)
hypersensitivity reactions.20 They are likely to be a
response to retained foreign material, such as nematocyst thread or
other cellular substances injected into the dermis, but specific
antigens have not been identified.
In our study, over half the patients followed up after stings positive
for C. fleckeri nematocysts had delayed skin eruptions
clinically resembling papular urticaria, similar to those reported
after other jellyfish stings.19-21 This confirms that
delayed cutaneous hypersensitivity reactions are common after
C. fleckeri stings. Corticosteroid cream, with or without
systemic antihistamines, may help relieve symptoms of delayed
reactions.1,7
Correlation of sticky-tape sampling with clinical presentation
suggests that there were no false-positive identifications of
C. fleckeri nematocysts. The false-negative rate is
unknown. However, as the test was negative for nematocysts in only
three cases that appeared clinically typical of C. fleckeri
envenomation, correlation with clinical findings appears
good.
While all the non-C. fleckeri nematocysts detected were
carybdeid in appearance, degenerate C. fleckeri
nematocysts may sometimes appear similar. Further description
and classification is needed of the Darwin carybdeid and other local
jellyfish yet to be identified. Clinical features of most of the
carybdeid nematocyst-positive stings differed from those of both
C. fleckeri stings and the Irukandji syndrome. The Darwin
carybdeid appears to cause local pain from tentacle marks, but this
pain is less severe than in C. fleckeri stings. The
Darwin carybdeid also causes some "overlap" systemic symptoms,
similar to those of a mild Irukandji syndrome. Two earlier stings with
these features were confirmed to be caused by the Darwin carybdeid
through capture and examination of the jellyfish, as well as
microscopic identification of nematocysts1 (Currie BJ, unpublished
data).
Finally, although life-threatening envenomation is uncommon, we
should continue to pursue public education and prevention policies
vigorously. Deaths from severe C. fleckeri envenomation
will inevitably occur while people, especially children without
protective clothing, enter tropical waters in Australia.
|
|
| |
Acknowledgements | |
We would like to acknowledge support from the Cooperative Research
Centre for Aboriginal and Tropical Health; from the National Health
and Medical Research Council Centre of Clinical Excellence grant to
the Northern Territory Clinical School, Royal Darwin Hospital; and
the staff of the Emergency Department, Royal Darwin Hospital,
particularly Carole Mansfield and Marg St Leone. We would also like to
acknowledge Phil Alderslade (Northern Territory Museum, Darwin)
for assistance and for the photograph of the Darwin carybdeid.
|
|
| |
Conflict of interest | |
There was no specific funding for this study and no conflict of
interest.
|
|
| |
References | |
- Williamson JA, Fenner PJ, Burnett JW, Rifikin JF. Venomous and
poisonous marine animals. 1st ed. Sydney: University of New South
Wales Press, 1996.
-
Williamson JA, Callanan VI, Hartwick RF. Serious envenomation by
the northern Australian box-jellyfish (Chironex
fleckeri). Med J Aust 1980; 1: 13-15.
-
Williamson JA, Le Ray LE, Wohlfahrt M, Fenner PJ. Acute management
of serious envenomation by box-jellyfish (Chironex
fleckeri). Med J Aust 1984; 141: 851-853.
-
Currie BJ. Clinical toxicology: a tropical Australian
perspective. Ther Drug Monit 2000; 22: 73-78.
-
Currie BJ, Khanh DM, Alderslade P, et al. Jellyfish envenomation in
the Northern Terrritory of Australia. Toxicon 1992; 30: 501.
-
Currie BJ, Wood YK. Identification of Chironex fleckeri
envenomation by nematocyst recovery from skin. Med J Aust
1995; 162: 478-480.
-
Currie B. Clinical implications of research on the box-jellyfish
Chironex fleckeri. Toxicon 1994; 32: 1305-1313.
-
Lumley J, Williamson JA, Fenner PJ, et al. Fatal envenomation by
Chironex fleckeri, the north Australian box jellyfish: the
continuing search for lethal mechanisms. Med J Aust 1988;
148: 527-534.
-
Barnes JH. Cause and effect in Irukandji stingings. Med J
Aust 1964; 1: 897-904.
-
Little M, Mulcahy RF. A year's experience of Irukandji
envenomation in far north Queensland. Med J Aust 1998; 169:
638-641.
-
Fenner PJ, Williamson JA, Callanan VI, Audley I. Further
understanding of, and a new treatment for, "Irukandji" (Carukia
barnesi) stings. Med J Aust 1986; 145: 569-574.
-
Currie B. Box-jellyfish in the Northern Territory. N T Dis
Control Bull 1998; 5: 12-14.
-
Guenin DG, Auerbach PS. Trauma and envenomations from marine
fauna. In: Tintinalli JE, Ruiz E, Krome RL, editors. Emergency
medicine — a comprehensive study guide. 4th ed. New York:
McGraw-Hill, 1996: 868-873.
-
Lill J. Fatal sting. Box jellyfish kills boy, 5. The Cairns Post
2000 Jan 25: 1.
-
King GK. Acute analgesia and cosmetic benefits of box-jellyfish
antivenom. Med J Aust 1991; 154: 365-366.
-
Beadnell CE, Rider TA, Williamson JA, Fenner PJ. Management of a
major box jellyfish (Chironex fleckeri) sting. Lessons from
the first minutes and hours. Med J Aust 1992; 156: 655-658.
-
Holmes JL. Marine stingers in far north Queensland. Australas
J Dermatol 1996; 37 Suppl 1: S23-S26.
-
Pereira PL, Carrette T, Cullen P, et al. Pressure immobilisation
bandages in first-aid treatment of jellyfish envenomation: current
recommendations reconsidered. Med J Aust 2000; 173:
650-652.
-
Reed KM, Bronstein BR, Baden HP. Delayed and persistent cutaneous
reactions to coelenterates. J Am Acad Dermatol 1984; 10:
462-465.
-
Pierard GE, Letot B, Pierard F. Histologic study of delayed
reactions to coelenterates. J Am Acad Dermatol 1990; 22:
599-601.
-
Burnett JW, Cobbs CS, Kelman SN, Calton GJ. Studies on the
serologic response to jellyfish envenomation. J Am Acad
Dermatol 1983; 9: 229-231.
(Received 20 Apr, accepted 13 Aug, 2001)
|
| |
Royal Darwin Hospital, Darwin, NT.
Gerard M O'Reilly, MB BS, Emergency Registrar; currently,
Emergency Registrar, Alfred Hospital, Melbourne, VIC.
Geoffrey K Isbister, BSc, MB BS, Emergency Registrar;
currently, Toxicology Registrar, Department of Clinical
Toxicology and Pharmacology, Newcastle Mater Hospital, Newcastle,
NSW.
Greg T Treston, DTMH, DIMCRCS, FACEM, Director of Emergency
Department; currently Consultant, Emergency Department, John
Flynn Hospital, Tugun, QLD.
Menzies School of Health Research, Darwin, NT.
Paula M Lawrie, BSc, Technical Officer.
Bart J Currie, FRACP, FAFPHM, DTMH, Head of Tropical Medicine
and International Health Unit; and Professor in Medicine, NT
Clinical School, Darwin, NT.
Reprints will not be available from the authors. Correspondence:
Professor B J Currie, Tropical Medicine and International Health
Unit, Menzies School of Health Research, PO Box 41096, Casuarina, NT
0811. bartATmenzies.edu.au
©MJA 2001
Make a
comment
Readers may print a single copy for personal use. No further
reproduction or distribution of the articles
should proceed without the permission of the publisher. For
permission, contact the
Australasian Medical Publishing Company.
Journalists are welcome to write news stories based on what they read here, but should acknowledge their source as "an article published on the Internet by The Medical Journal of Australia <http://www.mja.com.au>".
<URL: http://www.mja.com.au/>
© 2001 Medical Journal of Australia.
|
| |
|
|
| |
| |
| | Back to text |
| |
|
|
| |
|
|
2: Protocol for hospital treatment of Chironex fleckeri stings in the Northern Territory
1. If necessary, attend to airway, breathing and circulation and give oxygen.
2. Apply vinegar to the stings for at least 30 seconds to inactivate remaining nematocysts.
3. If patient is unconscious or has life-threatening cardiac or respiratory decompensation or significant arrhythmia, administer at least one ampoule of antivenom intravenously (20 000 units per ampoule, diluted 1:10 with an isotonic crystalloid solution such as Hartmann's solution or isotonic saline, given over 5-10 minutes). In a life-threatening situation where response remains inadequate, up to three ampoules may be given consecutively.
4. Cardiopulmonary resuscitation should be continued in a patient with ongoing cardiac arrest until after further therapy with antivenom (at least six ampoules total dose if available) and consideration of cardioactive drugs.
5. For non-life-threatening stings (no cardiac or respiratory decompensation), use ice-packs for initial pain relief, together with oral or parenteral analgesia if necessary (pethidine, 1 mg/kg up to 50 mg adult dose initially, or morphine, 0.1 mg/kg up to 5 mg initially, but can be repeated). For pain not relieved by ice-packs and narcotic analgesia, administer one ampoule of antivenom intravenously as above.
| |
|
| | Back to text |
| |
| |
| | Back to text |
|
| |
|
| 4: Chironex fleckeri stings |
|
|
|
A.

Severe sting on Day 2.
|
|
B.

Hypersensitivity reaction seen 10 days after a sting. |
| |
| | Back to text |
|
| |
|
| 5: Correlation between clinical presentation
and nematocyst identification in 39* jellyfish stings |
| |
|
|
|
|
|
Nematocyst appearance |
|
|
|
| Presentation |
Chironex fleckeri |
Other jellyfish† |
Not detected |
|
| Typical of C. fleckeri (n = 27)* |
23 |
1 |
3 |
| Not typical |
0 |
5 |
7 |
| "Irukandji" syndrome (n = 4) |
0 |
0 |
4 |
| Other (n = 8) |
0 |
5 |
3 |
|
* Nematocyst sampling was not performed in
one patient with a typical C. fleckeri presentation.
† All non-C. fleckeri-appearing nematocysts were consistent with carybdeid
nematocysts, although degenerate C. fleckeri nematocysts may sometimes look
similar. |
| |
| | Back to text |
| |
|